Jenburkt Pharmaceuticals Ltd banner

Jenburkt Pharmaceuticals Ltd
BSE:524731

Watchlist Manager
Jenburkt Pharmaceuticals Ltd Logo
Jenburkt Pharmaceuticals Ltd
BSE:524731
Watchlist
Price: 998 INR -0.6% Market Closed
Market Cap: ₹4.4B

Wall Street
Price Targets

JENBURPH Price Targets Summary
Jenburkt Pharmaceuticals Ltd

Wall Street analysts forecast JENBURPH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JENBURPH is 1 397.4 INR with a low forecast of 1 383.7 INR and a high forecast of 1 438.5 INR.

Lowest
Price Target
1 383.7 INR
39% Upside
Average
Price Target
1 397.4 INR
40% Upside
Highest
Price Target
1 438.5 INR
44% Upside
Jenburkt Pharmaceuticals Ltd Competitors:
Price Targets
M3C0
Mitsubishi Chemical Group Corp
-9% Downside
JEF
Jefferies Financial Group Inc
77% Upside
AMBR
Amber International Holding Ltd
338% Upside

Revenue
Forecast

7% / Year
Past Growth
-49% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
7% / Year
Past Growth
-49% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 13 years the compound annual growth rate for Jenburkt Pharmaceuticals Ltd's revenue is 7%. The projected CAGR for the next 3 years is -49%.

Operating Income
Forecast

12% / Year
Past Growth
-48% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
12% / Year
Past Growth
-48% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 13 years the compound annual growth rate for Jenburkt Pharmaceuticals Ltd's operating income is 12%. The projected CAGR for the next 3 years is -48%.

Net Income
Forecast

14% / Year
Past Growth
12% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
14% / Year
Past Growth
12% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 13 years the compound annual growth rate for Jenburkt Pharmaceuticals Ltd's net income is 14%. The projected CAGR for the next 3 years is 12%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is JENBURPH's stock price target?
Price Target
1 397.4 INR

According to Wall Street analysts, the average 1-year price target for JENBURPH is 1 397.4 INR with a low forecast of 1 383.7 INR and a high forecast of 1 438.5 INR.

What is Jenburkt Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
-49%

For the last 13 years the compound annual growth rate for Jenburkt Pharmaceuticals Ltd's revenue is 7%. The projected CAGR for the next 3 years is -49%.

What is Jenburkt Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
-48%

For the last 13 years the compound annual growth rate for Jenburkt Pharmaceuticals Ltd's operating income is 12%. The projected CAGR for the next 3 years is -48%.

What is Jenburkt Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
12%

For the last 13 years the compound annual growth rate for Jenburkt Pharmaceuticals Ltd's net income is 14%. The projected CAGR for the next 3 years is 12%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett